Jenal Lab Collaboration with Disperazol
INCATE, the innovation-support organisation for start-ups fighting drug-resistant infections, which was formed by NCCR AntiResist, has just closed its new call for Stage 1 awards and has selected three new companies.
Disperazol, one of the companies winning an award, collaborated with Jenal Lab, led by AntiResist’s Deputy Director Prof. Urs Jenal, a significant factor in the award. The results of the collaboration were published recently in Nature Microbiology.
